Browsing by Subject "Antineutrophil Cytoplasmic"
Now showing items 1-1 of 1
-
(Sociedad Médica Santiago, 2020)Cumulative survival in patients with anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (VAA) is 88 and 78% at 1 and 5 years, respectively. Despite this, mortality continues to be 2.7 times higher than the ...